IBM and Johnson & Johnson Team up in Santiago to Strengthen Community Resilience
The term “natural disaster” is a misnomer. Natural ecosystems often require disturbances such as fires and floods to remain healthy. They have an inherent resilience to the occasional battering. Crises created by destructive natural events might be more aptly referred to as “social disasters,” because of the toll of life and economic damage left in their wake. Framing such events as social disasters places them in a different light, shifting the burden on all sectors of society to proactively manage the threat.
The company has been honored with a spot on the prestigious list for the 17th year in a row for its innovative spirit and commitment to social responsibility, among other respected attributes.
The results are in, and Johnson & Johnson has been named to Fortune’s list of the World’s Most Admired Companies for the 17th year, ranking in the top 20. Johnson & Johnson also placed #1 in the Pharmaceutical category worldwide for the sixth consecutive year, making it the highest-ranked healthcare company to appear on the top companies list in 2019.
In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who's hard at work on the holy grail of HIV research: a preventive treatment.
By Sheila Weller
In 1992, as a young HIV/AIDS researcher in her native Netherlands, Hanneke Schuitemaker, Ph.D., now Vice President, Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines & Prevention B.V., was devoted to learning as much as she could about the disease—and saw her role as that of a researcher, rather than someone who closely interacted with people who were living with HIV.
The company has secured a top ranking on the biannual report—which grades companies on their efforts to make medicine more accessible to those in low- and middle-income countries—for the sixth consecutive time.
One billion. That's how many lives Johnson & Johnson is committed to impacting through its Health for Humanity 2020 Goals, which include a pledge to deliver innovative healthcare access to some of the world's most underserved communities and cutting-edge training programs for frontline healthcare workers.
It's one of the company's largest commitments to date, and it aims to help support the crucial work being done by frontline health workers to help more children grow up healthy.
If there's one universal truth about kids, it may be this: They want to grow up as quickly as possible. And for over 100 years, Johnson & Johnson has been working to help them grow up as healthy as possible, too.
The company is joining forces with more than 240 other organizations to be part of the New Plastics Economy Global Commitment for the good of the globe.
In 1947, decades before the concept of sustainability became popular, then Johnson & Johnson Chairman and CEO General Robert Wood Johnson wrote in his book, Or Forfeit Freedom: “We must use our resources wisely, avoiding waste of both raw materials and scrap, while we seek substitutes for things already in short supply.”
Company sets sights on 100% reusable, recyclable or compostable packaging by 2025
NEW BRUNSWICK, N.J., Oct. 31, 2018 /3BL Media/ - Johnson & Johnson Consumer, Inc. today announced the company is joining an ambitious effort to move the world closer to a circular economy in which plastic never becomes waste. Together with the Ellen MacArthur Foundation, the UN Environment Programme, and many industry-leading companies, governments, and NGOs this commitment will strive to meet goals to tackle one of the most urgent environmental issues of our time: plastic waste and the necessity of consumer packaging reform.